Boehringer Ingelheim and NIPER sign MoU on pharmaceutical research
Boehringer Ingelheim will provide NIPER Raebareli access to the opnMe portal, facilitating scientific advancement in healthcare.
Drug Development
Syngene and VivaMed collaborate on therapeutic programmes
Novartis enters licensing agreement with UNP for peptide therapeutics
MSD and Mayo Clinic team up to advance AI in drug development
Evogene and QUT partner on AI-based cancer therapies
J&J’s Rybrevant Faspro gains FDA approval for new dosing in NSCLC
RNA-targeting small molecules: a new frontier of drug discovery
Teijin and Aska Pharmaceutical to co-develop gynaecological drugs
